Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer

Archive ouverte

Meylan, Maxime | Petitprez, Florent | Becht, Etienne | Bougoüin, Antoine | Pupier, Guilhem | Calvez, Anne | Giglioli, Ilenia | Verkarre, Virginie | Lacroix, Guillaume | Verneau, Johanna | Sun, Chen-Ming | Laurent-Puig, Pierre | Vano, Yann-Alexandre | Elaïdi, Reza | Méjean, Arnaud | Sanchez-Salas, Rafaël | Barret, Eric | Cathelineau, Xavier | Oudard, Stephane | Reynaud, Claude-Agnès | de Reyniès, Aurélien | Sautès-Fridman, Catherine | Fridman, Wolf Herman

Edité par CCSD ; Elsevier -

International audience. The presence of intratumoral tertiary lymphoid structures (TLS) is associated with positive clinical outcomes and responses to immunotherapy in cancer. Here, we used spatial transcriptomics to examine the nature of B cell responses within TLS in renal cell carcinoma (RCC). B cells were enriched in TLS, and therein, we could identify all B cell maturation stages toward plasma cell (PC) formation. B cell repertoire analysis revealed clonal diversification, selection, expansion in TLS, and the presence of fully mature clonotypes at distance. In TLS+ tumors, IgG- and IgA-producing PCs disseminated into the tumor beds along fibroblastic tracks. TLS+ tumors exhibited high frequencies of IgG-producing PCs and IgG-stained and apoptotic malignant cells, suggestive of anti-tumor effector activity. Therapeutic responses and progression-free survival correlated with IgG-stained tumor cells in RCC patients treated with immune checkpoint inhibitors. Thus, intratumoral TLS sustains B cell maturation and antibody production that is associated with response to immunotherapy, potentially via direct anti-tumor effects.

Suggestions

Du même auteur

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

Archive ouverte | Vano, Yann-Alexandre | CCSD

International audience. Background: We previously reported a 35-gene expression classifier identifying four clear-cell renal cell carcinoma groups (ccrcc1 to ccrcc4) with different tumour microenvironments and sensi...

Tumor cells hijack macrophage-produced complement C1q to promote tumor growth

Archive ouverte | Roumenina, Lubka | CCSD

International audience. Clear-cell renal cell carcinoma (ccRCC) possesses an unmet medical need, particularly at the metastatic stage, when surgery is ineffective. Complement is a key factor in tissue inflammation, ...

The clinical role of the TME in solid cancer

Archive ouverte | Giraldo, Nicolas, A | CCSD

International audience. The highly complex and heterogenous ecosystem of a tumour not only contains malignant cells, but also interacting cells from the host such as endothelial cells, stromal fibroblasts, and a var...

Chargement des enrichissements...